Unity Biotechnology, Inc.
UBX
$0.977
-$0.0067-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.30M | -8.44M | -6.48M | -5.28M | -5.79M |
| Total Depreciation and Amortization | 178.00K | 203.00K | 216.00K | 221.00K | 227.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 666.00K | 1.71M | 516.00K | -797.00K | -559.00K |
| Change in Net Operating Assets | 101.00K | 625.00K | 556.00K | 1.27M | 939.00K |
| Cash from Operations | -6.36M | -5.91M | -5.19M | -4.58M | -5.18M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 7.00K | 0.00 | 19.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.78M | 4.58M | 6.50M | 4.67M | -7.21M |
| Cash from Investing | 6.78M | 4.58M | 6.51M | 4.67M | -7.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 9.00K | 0.00 | 68.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 9.00K | 0.00 | 68.00K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 419.00K | -1.32M | 1.31M | 154.00K | -12.37M |